Full coverage from day 2 (Oct 19th 2017) of the European Patient Summit 2017 below.
Day one coverage and more information can be found here.
South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral treatment for dengue fever, a mosquito-borne viral
The patient voice has grown in importance, and now it is being applied to develop and deliver more sophisticated drug delivery devices.
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
2024 is a pivotal year for the US healthcare sector.
The Industry’s Only Definitive Forum for Preclinical Heart Failure Drug Development
